Progression rates of colorectal cancer by Dukes' stage in a high-risk group

Analysis of selective colorectal cancer screening

Jau Min Wong, Ming Fang Yen, Mei Shu Lai, Stephen W. Duffy, Robert A. Smith, Tony Hsiu Hsi Chen

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

PURPOSE: The progression rates of colorectal cancer by Dukes' stage in a high-risk group were estimated and applied to evaluate the efficacy of different screening regimens. PATIENTS AND METHODS: Of 6303 high-risk subjects invited to a colorectal cancer screening project with colonoscopy, 39 screen-detected cases and 16 postscreening cases were diagnosed with information available on Dukes' stage. A five-state Markov process was applied to estimate parameters pertaining to the disease natural history of colorectal cancer by Dukes' stage. RESULTS: The estimates of the mean sojourn time in years were 3.10 for preclinical Dukes' A and B and 1.92 for preclinical Dukes' stages C and D. The predicted reductions of Dukes' stages C and D achieved by annual, biennial, 3-yearly, and 6-yearly screening regimens against the control group were 60%, 49%, 40%, and 25%, respectively. These, in turn, yield the corresponding predicted mortality reductions of 39%, 33%, 28%, and 18%. CONCLUSIONS: These findings suggest that to achieve a 30% mortality reduction, as observed in annual fecal occult blood testing, a prudent interscreening interval with colonoscopy for this high-risk group should not be longer than 3 years.

Original languageEnglish
Pages (from-to)160-169
Number of pages10
JournalCancer Journal
Volume10
Issue number3
DOIs
Publication statusPublished - May 2004
Externally publishedYes

Fingerprint

Early Detection of Cancer
Colorectal Neoplasms
Colonoscopy
Occult Blood
Markov Chains
Mortality
Control Groups

Keywords

  • Colonoscopy
  • Colorectal cancer screening
  • Dukes' stage
  • High-risk group
  • Markov process

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Progression rates of colorectal cancer by Dukes' stage in a high-risk group : Analysis of selective colorectal cancer screening. / Wong, Jau Min; Yen, Ming Fang; Lai, Mei Shu; Duffy, Stephen W.; Smith, Robert A.; Chen, Tony Hsiu Hsi.

In: Cancer Journal, Vol. 10, No. 3, 05.2004, p. 160-169.

Research output: Contribution to journalArticle

Wong, Jau Min ; Yen, Ming Fang ; Lai, Mei Shu ; Duffy, Stephen W. ; Smith, Robert A. ; Chen, Tony Hsiu Hsi. / Progression rates of colorectal cancer by Dukes' stage in a high-risk group : Analysis of selective colorectal cancer screening. In: Cancer Journal. 2004 ; Vol. 10, No. 3. pp. 160-169.
@article{026444691e174142930d6702cbe6f256,
title = "Progression rates of colorectal cancer by Dukes' stage in a high-risk group: Analysis of selective colorectal cancer screening",
abstract = "PURPOSE: The progression rates of colorectal cancer by Dukes' stage in a high-risk group were estimated and applied to evaluate the efficacy of different screening regimens. PATIENTS AND METHODS: Of 6303 high-risk subjects invited to a colorectal cancer screening project with colonoscopy, 39 screen-detected cases and 16 postscreening cases were diagnosed with information available on Dukes' stage. A five-state Markov process was applied to estimate parameters pertaining to the disease natural history of colorectal cancer by Dukes' stage. RESULTS: The estimates of the mean sojourn time in years were 3.10 for preclinical Dukes' A and B and 1.92 for preclinical Dukes' stages C and D. The predicted reductions of Dukes' stages C and D achieved by annual, biennial, 3-yearly, and 6-yearly screening regimens against the control group were 60{\%}, 49{\%}, 40{\%}, and 25{\%}, respectively. These, in turn, yield the corresponding predicted mortality reductions of 39{\%}, 33{\%}, 28{\%}, and 18{\%}. CONCLUSIONS: These findings suggest that to achieve a 30{\%} mortality reduction, as observed in annual fecal occult blood testing, a prudent interscreening interval with colonoscopy for this high-risk group should not be longer than 3 years.",
keywords = "Colonoscopy, Colorectal cancer screening, Dukes' stage, High-risk group, Markov process",
author = "Wong, {Jau Min} and Yen, {Ming Fang} and Lai, {Mei Shu} and Duffy, {Stephen W.} and Smith, {Robert A.} and Chen, {Tony Hsiu Hsi}",
year = "2004",
month = "5",
doi = "10.1097/00130404-200405000-00005",
language = "English",
volume = "10",
pages = "160--169",
journal = "Cancer journal (Sudbury, Mass.)",
issn = "1528-9117",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - Progression rates of colorectal cancer by Dukes' stage in a high-risk group

T2 - Analysis of selective colorectal cancer screening

AU - Wong, Jau Min

AU - Yen, Ming Fang

AU - Lai, Mei Shu

AU - Duffy, Stephen W.

AU - Smith, Robert A.

AU - Chen, Tony Hsiu Hsi

PY - 2004/5

Y1 - 2004/5

N2 - PURPOSE: The progression rates of colorectal cancer by Dukes' stage in a high-risk group were estimated and applied to evaluate the efficacy of different screening regimens. PATIENTS AND METHODS: Of 6303 high-risk subjects invited to a colorectal cancer screening project with colonoscopy, 39 screen-detected cases and 16 postscreening cases were diagnosed with information available on Dukes' stage. A five-state Markov process was applied to estimate parameters pertaining to the disease natural history of colorectal cancer by Dukes' stage. RESULTS: The estimates of the mean sojourn time in years were 3.10 for preclinical Dukes' A and B and 1.92 for preclinical Dukes' stages C and D. The predicted reductions of Dukes' stages C and D achieved by annual, biennial, 3-yearly, and 6-yearly screening regimens against the control group were 60%, 49%, 40%, and 25%, respectively. These, in turn, yield the corresponding predicted mortality reductions of 39%, 33%, 28%, and 18%. CONCLUSIONS: These findings suggest that to achieve a 30% mortality reduction, as observed in annual fecal occult blood testing, a prudent interscreening interval with colonoscopy for this high-risk group should not be longer than 3 years.

AB - PURPOSE: The progression rates of colorectal cancer by Dukes' stage in a high-risk group were estimated and applied to evaluate the efficacy of different screening regimens. PATIENTS AND METHODS: Of 6303 high-risk subjects invited to a colorectal cancer screening project with colonoscopy, 39 screen-detected cases and 16 postscreening cases were diagnosed with information available on Dukes' stage. A five-state Markov process was applied to estimate parameters pertaining to the disease natural history of colorectal cancer by Dukes' stage. RESULTS: The estimates of the mean sojourn time in years were 3.10 for preclinical Dukes' A and B and 1.92 for preclinical Dukes' stages C and D. The predicted reductions of Dukes' stages C and D achieved by annual, biennial, 3-yearly, and 6-yearly screening regimens against the control group were 60%, 49%, 40%, and 25%, respectively. These, in turn, yield the corresponding predicted mortality reductions of 39%, 33%, 28%, and 18%. CONCLUSIONS: These findings suggest that to achieve a 30% mortality reduction, as observed in annual fecal occult blood testing, a prudent interscreening interval with colonoscopy for this high-risk group should not be longer than 3 years.

KW - Colonoscopy

KW - Colorectal cancer screening

KW - Dukes' stage

KW - High-risk group

KW - Markov process

UR - http://www.scopus.com/inward/record.url?scp=4644312369&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=4644312369&partnerID=8YFLogxK

U2 - 10.1097/00130404-200405000-00005

DO - 10.1097/00130404-200405000-00005

M3 - Article

VL - 10

SP - 160

EP - 169

JO - Cancer journal (Sudbury, Mass.)

JF - Cancer journal (Sudbury, Mass.)

SN - 1528-9117

IS - 3

ER -